04 May 2021

Virtual poster discussion session 1

Watch the replay

Agenda

  • Iona Cuthbertson // Therapeutically targeting endothelial cell metabolic dysfunction in pulmonary arterial hypertension with apigenin
  • Prakash Chelladurai // Epigenome-wide profiling uncovers novel gene regulatory networks in human pulmonary arterial hypertension
  • Charifa Awada // Implication of the histone methyltransferase “g9a” in pulmonary arterial hypertension
  • Barbora Kaftanová // Perinatal exposure to serotonin re-uptake inhibitor causes mild pulmonary hypertension in adult female rats
  • Anandharajan Rathinasabapath // Endothelial overexpression of sirt3 protects the metabolic etiology in PAH
  • Tatyana Novoyatleva // Axl is a novel modulator of bone morphogenetic protein receptor 2 in pulmonary arterial hypertension
  • Katherine Kearney Graham // Equivalent outcomes for hereditary and idiopathic pulmonary arterial hypertension in children; an analysis from a national Australian registry
  • Richard Channick // Effect of macitentan across prognostic age groups in patients with pulmonary arterial hypertension (PAH)
  • Pietro Nardelli // Validation of artificial intelligence artery-vein Classification for Contrast CT imaging in PH subjects
  • Victor Tapson // Efficacy in patient subgroups in the INCREASE Trial, a phase III Trial to evaluate inhaled Treprostinil in patients with pulmonary hypertension due to parenchymal Lung Disease
  • Erik Swenson // Acetazolamide and high altitude pulmonary edema prevention
  • Manjula Miglani // Telomeric Tankyrases: a novel and propitious target to ameliorate the maladaptation phenomena at heights


Comments (0)

Our research platform is the world.

Through worldwide collaboration, we can begin to answer the question of a global disease.

Join the PVRI
standard-example-image.jpg